Alcon to Acquire LumiThera, Expanding into Dry AMD Treatment
PBM therapy meets eye care giant muscle in Alcon’s latest AMD acquisition. Alcon (Geneva, Switzerland) is turning up the brightness…
Eylea 8 mg Approved in EU for 6-Month Dosing in nAMD and DME
EU expands Eylea 8 mg label to include longer intervals for nAMD and DME The European Commission (EC) has approved…
popular posts
latest posts
